GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $137.78 $156.84 Friday, 19th Apr 2024 ASND stock ended at $140.17. This is 0.511% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.81% from a day low at $137.78 to a day high of $144.41.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
2024-02-07 $141.94 $142.16 $138.91 $139.29 653 969
2024-02-06 $143.64 $144.95 $140.27 $140.84 359 766
2024-02-05 $139.77 $143.54 $136.79 $143.09 466 556
2024-02-02 $139.43 $143.76 $139.40 $139.77 416 855
2024-02-01 $130.60 $141.75 $129.25 $141.63 602 562
2024-01-31 $129.16 $132.73 $128.67 $129.93 629 068
2024-01-30 $133.53 $133.53 $129.16 $129.20 289 870
2024-01-29 $132.61 $135.35 $131.38 $134.39 175 760
2024-01-26 $132.10 $134.65 $131.00 $132.46 369 311
2024-01-25 $135.09 $135.20 $131.01 $131.75 270 767
2024-01-24 $137.28 $137.56 $133.77 $134.12 233 813
2024-01-23 $134.63 $137.03 $132.36 $136.50 317 641
2024-01-22 $131.80 $135.58 $131.25 $134.16 325 898
2024-01-19 $132.86 $133.00 $130.26 $132.02 268 868
2024-01-18 $132.61 $133.98 $129.55 $132.98 387 714
2024-01-17 $132.16 $133.71 $130.72 $132.40 916 881
2024-01-16 $130.85 $134.15 $128.68 $133.50 546 049
2024-01-12 $135.82 $138.50 $131.01 $131.23 358 126
2024-01-11 $136.85 $138.10 $134.61 $135.43 203 324
2024-01-10 $137.16 $138.38 $135.56 $136.90 313 296
2024-01-09 $138.24 $140.00 $135.48 $137.10 360 943
2024-01-08 $131.00 $139.06 $127.70 $138.24 447 673
2024-01-05 $122.60 $130.47 $119.03 $129.72 353 012
2024-01-04 $123.53 $125.76 $122.76 $123.83 429 910
2024-01-03 $125.88 $127.04 $122.79 $123.45 283 121
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT